Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03330561
Title PRS-343 in HER2-Positive Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pieris Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Arizona Cancer Center Tucson Arizona 85719 United States Details
University of California Los Angeles (UCLA) Santa Monica California 90404 United States Details
Georgetown University, Lombardi Comprehensive Cancer Center Washington District of Columbia 20007 United States Details
Johns Hopkins University School of Medicine Baltimore Maryland 21287 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
University of Pittsburgh Medical Center (UPMC) Pittsburgh Pennsylvania 15213 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
M.D. Anderson Cancer Center Houston Texas 77030 United States Details
NEXT Oncology San Antonio Texas 78229 United States Details
START - South Texas Accelerated Research Therapeutics, LLC San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field